DUOS, a technology-enabled service provider, has raised $130 million to expand its platform to more health plans across the country, it announced on Thursday. The Minneapolis-based company supports ...

Healthcare has been moving steadily out of the clinic and into the home. McKinsey estimates that as much as $265 billion in care (nearly a quarter of all Medicare spending) could shift from facilities ...

At MedCity News’ INVEST Digital Health conference, healthcare experts explored strategies to mitigate automation bias — emphasizing the importance of vendor responsibility, use case-specific ...

Boehringer Ingelheim established a presence in idiopathic pulmonary fibrosis years ago with a drug that has become a standard treatment for this serious lung disorder. Now the company has the ...

CertifyOS, a provider data intelligence company, has launched a new platform to help payers manage provider data in their network, the company announced last week. New York City-based CertifyOS serves ...

The government shutdown is drawing backlash from healthcare leaders over its potential to disrupt ACA subsidies, Medicare ...

MedCity News Editor in Chief Arundhati Parmar and Samir Batra, managing partner of Health Innovation Pitch, also discussed ...

Newly launched Pfizer drugs will be priced at parity to prices in comparable developed nations, according to the most-favored ...

Clinicians are drowning in documentation-related work, with mountains of patient data to sift through before they can even begin writing a note. Cedars-Sinai believes its new partnership with Regard ...

Market conditions continue to pose challenges for startups trying to raise money. Some of these companies might be a fit for Sanofi’s corporate venture capital arm, which the pharmaceutical giant has ...

Drugs for the rare hormone disorder acromegaly include older engineered peptides administered as frequent injections. A new FDA approval brings acromegaly patients the choice of a once-daily pill that ...